Breast cancer is the second most common type of cancer in the world. Polyphenols can act at all stages of carcinogenesis and oxyresveratrol (OXY) promising anticancer properties, mainly associated with chemotherapy drugs. The aim of this study was to investigate the effect of OXY with doxorubicin (DOX) or melphalan (MEL), either isolated or associated, in MCF-7 and MDA-MB-231 breast cancer cells. Our results showed that OXY, DOX, and MEL presented cytotoxicity, in addition to altering cell morphology. The synergistic association of OXY + DOX and OXY + MEL reduced the cell viability in a dose-dependent manner. The OXY, DOX, or MEL and associations were able to alter the ROS production, ∆Ψm, and cell cycle; DOX and OXY + DOX led the cells to necrosis. Furthermore, OXY and OXY + MEL were able to lead the cells to apoptosis and upregulate caspases-3, -7, -8, and -9 in both cells. LC-HRMS showed that 7-deoxidoxorubicinone and doxorubicinol, responsible for the cardiotoxic effect, were not identified in cells treated with the OXY + DOX association. In summary, our results demonstrate for the first time the synergistic effect of OXY with chemotherapeutic agents in breast cancer cells, offering a new strategy for future animal studies.
1 January 2020 in Anais da Academia Brasileira de Ciências
Leishmaniasis is caused by protozoan parasites belonging to the genus Leishmania and includes cutaneous, mucocutaneous and visceral clinical forms. Drugs currently available for leishmaniasis treatment present high toxicity, and development of parasite resistance. Plants constitute an important source of compounds with leishmanicidal potential. This study aimed to evaluate the anti-Leishmania amazonensis activity of the terpenoid fraction of Eugenia pruniformis leaves (TF-EpL). TF-EpL was active against the promastigote and intracellular amastigote forms of L. amazonensis with IC50(24h) value of 43.60μg/mL and 44.77μg/mL, respectively. TF-EpL altered the cell cycle of the parasite, increasing 2.32-fold the cells in the Sub-G0/G1 phase. TF-EpL also changed the ΔΨm and increased ROS and the number of annexin-V-PI positive promastigotes, which suggests incidental death. β-sitosterol, ursolic acid, corosolic acid and asiatic acid were isolated from TF-EpL. The results showed the antileishmanial activity of E. pruniformis terpenoids and its potential for further studies as a source of new drugs for leishmaniasis.
1 January 2020 in Brazilian Journal of Development
Avaliação físico-química e capacidade antioxidante do extrato de buriti (Mauritia flexuosa L.) e atividade antitumoral em linhagem celular de câncer de mama MDA-MB-231 / Physico-chemical evaluation and antioxidant capacity of buriti extract and antitumor activity in breast cancer cell line MDA-MB-231
Anais do Simpósio Estadual de Produtos Naturais (978-65-5941-203-7) - Oxyresveratrol Induz Apoptose Em Células De Câncer De Mama Agressivo Via Caspase-3
Anais do Simpósio Estadual de Produtos Naturais (978-65-5941-203-7) - Extrato Bruto Dos Frutos Da Bonnetia Sp. Altera O Ciclo Celular De Células De C Ncer De Mama
Perillic acid (PA), a monocyclic monoterpene derived from limonene, was evaluated for its leishmanicidal activity alone and in combination with miltefosine, as well as in its microemulsion‐based formulation. PA demonstrated synergistic activity with miltefosine and was effective against both promastigote and amastigote forms of Leishmania amazonensis . Its anti‐amastigote effect was independent of nitric oxide production but was partially associated with reduced arginase activity in stimulated macrophages. In a murine model of cutaneous leishmaniasis, topical treatment with a PA‐loaded microemulsion resulted in a marked reduction in parasite burden, achieving a 99% reduction in L. amazonensis infections. PA also showed efficacy in vivo across different administration routes and showed significant skin permeation when formulated in a microemulsion. These findings highlight PA as a promising leishmanicidal agent and support its potential application in the treatment of cutaneous leishmaniasis.